InsidersTradesSigma
Browse the full record of transactions filed by LLOYD RONALD K., Chairman & CEO. Director active across 1 company, notably Aziyo Biologics, INC.. Cumulatively, 1 reports have been recorded. Activity tracked since 8 March 2022. The latest transaction was disclosed on 8 March 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration
Ronald K. Lloyd is the President and CEO of Aziyo Biologics, Inc. He is responsible for the strategic direction of the company, which specializes in developing biological solutions for regenerative medicine. Aziyo Biologics, Inc. is committed to improving patient outcomes through innovative technologies.